Although dual blockade of the renin-angiotensin-aldosterone system (RAAS) with the
combination of an angiotensin-converting enzyme inhibitor (ACE-I) and angiotensin II …

BACKGROUND: Agents inhibiting the renin-angiotensin-aldosterone (RAAS) system have
an important role in slowing the progression of chronic kidney disease. We evaluated the …

Studies have shown that dual therapy with angiotensin-converting enzyme inhibitors (ACEI)
and either angiotensin II receptor blockers or aldosterone receptor antagonists is more …

Dual blockade of the renin-angiotensin-aldosterone system (RAAS) with both ACE inhibitors
and angiotensin II receptor-blockers has been shown to reduce both albuminuria and blood …

Introduction Aldosterone seems to have deleterious effects on the kidneys. Many animal
studies and a few clinical trials have shown that suppression of aldosteroneby aldosterone …

The renin–angiotensin–aldosterone system (RAAS), an important regulator of blood
pressure as well as fluid and electrolyte balance, plays an important role in the …

Clinical and experimental studies have shown that the initial suppression of angiotensin II
after the administration of angiotensin-converting enzyme (ACE) inhibitors is later reversed …

BACKGROUND Although dual blockade of the renin–angiotensin–aldosterone system
(RAAS) has gained popularity for the treatment of kidney disease, its benefits and potential …

Aim: To evaluate the effects of combined treatment of an ACE inhibitor and an angiotensin II
receptor antagonist on parameters related to the progression of renal disease in type 2 …

Renin-angiotensin-aldosterone system (RAAS) inhibition exerts a renoprotective effect
independent of blood pressure reduction. Many studies using an end-point of proteinuria …